Recombinant Human MECP2 Protein: Research Guide & Applications

Recombinant Human MECP2 Protein is a critical epigenetic regulator produced for research use, enabling scientists to investigate methyl-CpG-dependent transcriptional repression, neuronal function, and the molecular mechanisms underlying Rett syndrome.

Protein Name

Methyl-CpG Binding Protein 2 (MECP2)

SKU

rp370671

Species Origin

Human (Homo sapiens)

Protein Function

Transcriptional repressor that binds methylated CpG dinucleotides; key regulator of neuronal gene expression

Primary Research Areas

Epigenetics, Rett syndrome, neurodevelopment, chromatin regulation

Storage Recommendation

Avoid repeated freeze-thaw cycles; aliquot upon receipt (verify with datasheet)

Biological Background and Function of MECP2

Methyl-CpG Binding Protein 2 (MECP2) is an X-linked nuclear protein that plays a central role in epigenetic gene regulation. It was first identified as a protein capable of binding specifically to methylated CpG dinucleotides within DNA, linking DNA methylation to transcriptional silencing. MECP2 contains two well-characterized functional domains: the Methyl-CpG Binding Domain (MBD), which mediates selective recognition of methylated DNA, and the Transcriptional Repression Domain (TRD), which recruits co-repressor complexes including Sin3A and histone deacetylases (HDACs) to silence target gene expression.

MECP2 is expressed ubiquitously but is most abundantly found in post-mitotic neurons, where it functions as a global chromatin organizer. Beyond transcriptional repression, emerging evidence indicates that MECP2 also contributes to transcriptional activation, RNA splicing regulation, and chromatin compaction. Loss-of-function mutations in the MECP2 gene are the primary genetic cause of Rett syndrome, a severe X-linked neurodevelopmental disorder predominantly affecting females. Conversely, duplication of the MECP2 locus leads to MECP2 Duplication Syndrome, underscoring the critical importance of precise MECP2 dosage in neurological homeostasis.

Recommended Handling and Storage Protocol

To maintain the activity and integrity of Recombinant Human MECP2 Protein (rp370671), researchers should follow rigorous handling procedures. Upon receipt, briefly centrifuge the vial to consolidate the contents before opening. It is strongly recommended to aliquot the protein into single-use volumes immediately upon first thaw to minimize degradation caused by repeated freeze-thaw cycles.

Recommended storage conditions: Store at -20°C or -80°C as indicated on the product datasheet. Working aliquots may be stored at 4°C for short-term use (typically up to one week); however, always refer to the specific product datasheet for authoritative storage guidance. Avoid exposing the protein to repeated temperature fluctuations or prolonged storage at room temperature, as this may compromise structural integrity and binding activity.

Reconstitution: If supplied in lyophilized form, reconstitute with the buffer specified in the datasheet. Allow the protein to equilibrate briefly at room temperature before use, and mix gently by pipetting—do not vortex. Confirm protein concentration by standard methods such as Bradford assay or absorbance at 280 nm before use in downstream assays. All specific concentration values and buffer compositions should be confirmed against the product datasheet provided with each lot.

Research Applications

Recombinant Human MECP2 Protein is a versatile tool for a broad range of biochemical and cell biology applications. Key validated and commonly reported uses include:

• Electrophoretic Mobility Shift Assay (EMSA): MECP2 protein is used to study its binding affinity and specificity for methylated versus unmethylated DNA substrates in vitro, providing mechanistic insights into its epigenetic reader function.
• Chromatin Immunoprecipitation (ChIP) controls: Recombinant MECP2 may serve as a positive control or standard in ChIP-related experiments investigating genome-wide occupancy of MECP2 at methylated loci.
• Protein–protein interaction studies: Co-immunoprecipitation (Co-IP) and pull-down assays utilize recombinant MECP2 to identify and validate interaction partners, including transcriptional co-repressors and chromatin remodeling complexes.
• Biochemical activity assays: The protein can be employed in in vitro transcription repression assays and nucleosome binding experiments to dissect domain-specific functions of MECP2.
• Drug screening and therapeutic target validation: Recombinant MECP2 is used in compound screening platforms aimed at identifying small molecules that modulate MECP2 binding or restore function in Rett syndrome models.

Always confirm specific validated applications with the product datasheet, as performance may vary by lot and assay format.

Quality, Purity, and Formulation Considerations

Recombinant Human MECP2 Protein (rp370671) is manufactured for research use. Quality parameters typically evaluated for recombinant proteins of this class include:

• Purity: Assessed by SDS-PAGE and/or HPLC; target purity specifications are defined per lot and provided on the Certificate of Analysis (CoA). Researchers should request the CoA for each lot received.
• Endotoxin levels: Low endotoxin formulations are important for cell-based assays. Endotoxin content should be confirmed from the CoA before use in sensitive biological systems.
• Biological activity: Functional activity is typically confirmed through DNA-binding assays verifying selective recognition of methylated CpG sequences.
• Formulation: Specific buffer composition, stabilizing agents, and protein concentration are lot-dependent and must be verified on the product datasheet or CoA supplied with each shipment.

Researchers are advised to validate the protein in their specific assay system upon first use, particularly when switching between lots, to ensure reproducibility of experimental results.

Frequently asked questions

What is MECP2 and why is it important in neuroscience research?

MECP2 (Methyl-CpG Binding Protein 2) is a nuclear protein that binds methylated DNA and regulates gene expression through transcriptional repression. It is critically important in neurons, where it acts as a global chromatin organizer. Loss-of-function mutations in MECP2 cause Rett syndrome, making it a primary target in neurodevelopmental disorder research.

What applications is Recombinant Human MECP2 Protein (rp370671) suitable for?

Recombinant Human MECP2 Protein is commonly used in EMSA for DNA-binding studies, protein–protein interaction assays (Co-IP, pull-down), in vitro transcription repression assays, ChIP controls, and drug/compound screening platforms. Please consult the product datasheet to confirm validated applications for each specific lot.

How should Recombinant Human MECP2 Protein be stored to maintain activity?

The protein should be stored at -20°C or -80°C as specified in the product datasheet. Aliquot the protein into single-use volumes upon first thaw to avoid repeated freeze-thaw cycles, which can degrade activity. Short-term working aliquots may be kept at 4°C. Always refer to the datasheet for lot-specific storage instructions.

How can I confirm the purity and activity of each lot of MECP2 protein?

Request the Certificate of Analysis (CoA) for each lot received. The CoA will detail purity as assessed by SDS-PAGE or HPLC, endotoxin content, and functional activity data from DNA-binding assays. It is best practice to independently validate the protein in your specific assay system when switching between lots.

Is Recombinant Human MECP2 Protein suitable for use in cell-based assays?

Recombinant Human MECP2 Protein may be used in cell-based contexts where endotoxin levels are low enough to avoid interference with cellular responses. Always verify the endotoxin specification on the product CoA before use in sensitive cell-based assays, and confirm suitability for your specific cell system.

References

1. Lewis JD, et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell. 1992;69(6):905-914.
2. Amir RE, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics. 1999;23(2):185-188.
3. Nan X, et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 1998;393(6683):386-389.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.